KYAN Technologies key facts
as of Oct 2026- Developer of functional precision medicine technology designed to bridge the cancer care gap by advancing technologies.
- KYAN Technologies is valued at approximately $18.1M as of Oct 2026 (last reported valuation).
- It has raised $8.2M; the latest was Later Stage VC ($3.2M) in Jun 2025.
- Notable investors include SEEDS Capital, K3 Ventures, RNT Associates, Altara Ventures, Enterprise Singapore.
- Status: Privately Held (backing).
KYAN Technologies's last reported valuation, Jun 2025. Nothing priced has surfaced since.
- ·Watch KYAN Technologies: the Monday email on marks, rounds and moves
KYAN Technologies funding rounds
No funding rounds for KYAN Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs KYAN Technologies
5KYAN Technologies valuation
KYAN Technologies's last reported valuation was $18.1 million in Jun 2025. No priced round, secondary trade or fund mark has surfaced since.
KYAN Technologies investors
5 investors are on record for KYAN Technologies, including SEEDS Capital, K3 Ventures, RNT Associates and Altara Ventures.
About KYAN Technologies
Developer of functional precision medicine technology designed to bridge the cancer care gap by advancing technologies. The company's technology identifies safe and useful drug-dose combinations based on small inputs of data, as well as transforms the way patients are treated and therapies are developed, enabling the medical industry to create multiple drugs in the field of oncology and infectious diseases.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2016
- Employees
- 6
- Website
- kyantechnologies.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.